Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy.
about
Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathyTranscoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients.The Brockenbrough-Braunwald-Morrow sign.Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case reportEthanol infusion in the vein of Marshall leads to parasympathetic denervation of the human left atrium: implications for atrial fibrillation.Visualization of transcoronary ablation of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: a comparison between cardiac MRI, invasive measurements and echocardiography.Non-coronary percutaneous interventionApical myocardial injury caused by collateralisation of a septal artery during ethanol septal ablation.Hypertrophic cardiomyopathy: state-of-the-art review, with focus on the management of outflow obstruction.Alcohol septal ablation for obstructive hypertrophic cardiomyopathyTechnology insight: transcoronary ablation of septal hypertrophy.Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.The "1st septal unit" in hypertrophic obstructive cardiomyopathy: a newly recognized anatomo-functional entity, identified during recent alcohol septal ablation experience.Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathiesContemporary treatment of hypertrophic cardiomyopathyCardiac conduction system: delineation of anatomic landmarks with multidetector CT.Alcohol septal ablation for hypertrophic obstructive cardiomyopathy - 8 years follow up.Adverse fibrosis in the aging heart depends on signaling between myeloid and mesenchymal cells; role of inflammatory fibroblasts.Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report.Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.Effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy on Doppler Tei index: a midterm follow-up.Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy.Incidence and predictors of late complete heart block after alcohol septal ablation treatment of hypertrophic obstructive cardiomyopathy.Septal alcohol ablation and Heyde's syndrome revisited.Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy.Alcohol septal ablation for obstructive hypertrophic cardiomyopathy.Initial experience with alcohol septal ablation using a novel magnetic navigation system.Hypertrophic obstructive cardiomyopathy: review of surgical treatment.Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?Predictors of complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy and the timing of pacemaker implantation.
P2860
Q24197872-BFDF851B-CBC5-4FAE-8CF9-559FCB7CD4C1Q33151393-1E1DB403-84A1-4097-8D4B-2BCB4BB09C70Q33164424-2C7853D4-86B7-4FF0-AD2A-AE84E3E59B42Q33239512-B9576CBF-489F-4F47-9A66-E9028FCBBDCEQ33669607-36281890-5EDD-4E8A-84CD-0735522B3736Q33876155-0E1B0EA7-7E07-41B1-9D50-E6C92699F1B4Q35175556-C85EFAFE-D365-48CF-AB1A-095A8098B6AFQ35583412-0B411A38-1C4A-43F6-A097-1D2954F05901Q35600527-2CC5398D-8049-4090-99DC-BF80D4C80E7CQ35772518-B3C84CD5-63D7-499B-90B7-438086696CF2Q36304243-5A59C168-D3E7-4E8D-AF83-BC484749C6ECQ36553727-723F259E-D90F-4194-8CA4-21A7D6BB7B43Q36975773-69A28F3D-22FD-4DCA-B986-AAD1C793C549Q37061992-723D41ED-C4E2-4287-A3E1-1B1E958B639AQ37227838-5324A078-1555-47A3-AA71-E5A538D18065Q37398106-68EFA17B-721C-4BBF-A35A-C9D0834F18BCQ37446032-ABCFCD69-E39B-4C3D-9980-290F7B7027DCQ38159348-69BAC730-14EB-4FF6-B128-D516C982C5ACQ39295158-590D4959-1639-4FC3-B57D-24FB6CFFB5E5Q39307255-490ACEFD-277F-482B-AACA-702D0ACA371EQ39371047-7550BC19-BF0A-48DA-B1D4-40EDE563A432Q39747435-D77A1E65-DEC0-48CB-88CC-D13C52C4D80EQ41416607-A6518402-1939-4AF5-B175-053467E0AAD5Q44373689-731133D9-B26A-4295-84F5-2DA416119424Q45769504-1724B86F-C864-41F6-A732-C0722EAD28F7Q46399015-7189923E-40B0-422F-9EA2-BC6DE30356F3Q46879876-1D37FE13-90AE-47B5-934E-3287ADA116A7Q48356277-AABF0C7C-6E36-4433-8F79-9C04BDF9B943Q50783277-7AA65369-88AA-47CC-ACE8-4ADA6E5DA1FFQ50950319-E09D5E8F-D0B0-48DC-87C9-F6803FA3647AQ51065437-AB265254-EEB4-44DF-8547-4BCD61CE6A96
P2860
Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Comparison of ethanol septal r ...... ic obstructive cardiomyopathy.
@en
Comparison of ethanol septal r ...... ic obstructive cardiomyopathy.
@nl
type
label
Comparison of ethanol septal r ...... ic obstructive cardiomyopathy.
@en
Comparison of ethanol septal r ...... ic obstructive cardiomyopathy.
@nl
prefLabel
Comparison of ethanol septal r ...... ic obstructive cardiomyopathy.
@en
Comparison of ethanol septal r ...... ic obstructive cardiomyopathy.
@nl
P2093
P1476
Comparison of ethanol septal r ...... ic obstructive cardiomyopathy.
@en
P2093
Danielson GK
Quiñones MA
Spencer WH
P304
P356
10.1016/S0735-1097(01)01614-X
P407
P577
2001-11-01T00:00:00Z